logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/05/2025
Market news: Elon Musk's brain-machine interface company Neuralink has launched the first clinical trial in the Middle East region at a clinic in Abu Dhabi's Cleveland.
Latest
9 m ago
Craig-Hallum: Maintaining Fennec Pharmaceuticals (FENC.US) rating, adjusting from Buy to Buy rating, target price adjusted from $12.00 to $13.00.
12 m ago
Craig-Hallum: Maintain rating for Biodesix (BDSX.US), adjusting from buy to hold rating, target price adjusted from $3.00 to $1.50.
13 m ago
Craig-Hallum: Maintains a buy rating for Eton Pharmaceuticals (ETON.US), adjusted from a buy rating to a buy rating, with a target price adjusted from $26.00 to $28.00.
16 m ago
HC Wainwright & Co. maintains its rating on Revolution Medicines (RVMD.US) and adjusts its recommendation from buy to buy, with a target price adjustment from $73.00 to $72.00.
16 m ago
Citigroup: Maintains a neutral rating on Lowe's Companies (LOW.US), adjusting the target price from $269.00 to $253.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.